ICU Medical Inc
NASDAQ:ICUI

Watchlist Manager
ICU Medical Inc Logo
ICU Medical Inc
NASDAQ:ICUI
Watchlist
Price: 159.75 USD 1.27% Market Closed
Market Cap: 3.9B USD
Have any thoughts about
ICU Medical Inc?
Write Note

ICU Medical Inc
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

ICU Medical Inc
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
ICU Medical Inc
NASDAQ:ICUI
Cash & Cash Equivalents
$312.5m
CAGR 3-Years
-16%
CAGR 5-Years
0%
CAGR 10-Years
2%
Haemonetics Corp
NYSE:HAE
Cash & Cash Equivalents
$299.3m
CAGR 3-Years
16%
CAGR 5-Years
22%
CAGR 10-Years
9%
DENTSPLY SIRONA Inc
NASDAQ:XRAY
Cash & Cash Equivalents
$296m
CAGR 3-Years
2%
CAGR 5-Years
6%
CAGR 10-Years
12%
Align Technology Inc
NASDAQ:ALGN
Cash & Cash Equivalents
$1B
CAGR 3-Years
-6%
CAGR 5-Years
16%
CAGR 10-Years
19%
Lantheus Holdings Inc
NASDAQ:LNTH
Cash & Cash Equivalents
$866.4m
CAGR 3-Years
112%
CAGR 5-Years
62%
CAGR 10-Years
41%
Merit Medical Systems Inc
NASDAQ:MMSI
Cash & Cash Equivalents
$523.1m
CAGR 3-Years
97%
CAGR 5-Years
70%
CAGR 10-Years
55%
No Stocks Found

ICU Medical Inc
Glance View

Market Cap
3.9B USD
Industry
Health Care

ICU Medical, Inc. engages in the development, manufacture, and sale of innovative medical devices used in vascular therapy and critical care applications. The company is headquartered in San Clemente, California and currently employs 8,500 full-time employees. The firm provides infusion systems, infusion consumables and critical care products used in hospital, alternate site and home care settings. The firm's product portfolio includes IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needle free connectors. Its oncology products include ChemoLock and ChemoClave. Its IV consumables include Clave IV Connector Technology, IV Sets, Peripheral IV Catheters and Disinfecting Caps. Its primary critical care products include Cogent, CardioFlo, TDQ and OptiQ, TriOx, Transpac and SafeSet. Its IV Solutions products include IV Therapy and Diluents, and Irrigation. Its Infusion System products include Infusion Pump Hardware, IV Mediation Safety Software and Professional Services. The company offers blood pressure monitoring system.

ICUI Intrinsic Value
193.3 USD
Undervaluation 17%
Intrinsic Value
Price

See Also

What is ICU Medical Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
312.5m USD

Based on the financial report for Sep 30, 2024, ICU Medical Inc's Cash & Cash Equivalents amounts to 312.5m USD.

What is ICU Medical Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
2%

Over the last year, the Cash & Cash Equivalents growth was 58%. The average annual Cash & Cash Equivalents growth rates for ICU Medical Inc have been -16% over the past three years , and 2% over the past ten years .

Back to Top